Bicara Therapeutics Inc. Common Stock (BCAX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bicara Therapeutics Inc. ...

    NASDAQ: BCAX · Real-Time Price · USD
    11.19
    0.69 (6.57%)
    At close: Sep 24, 2025, 3:59 PM
    11.41
    1.97%
    After-hours: Sep 24, 2025, 06:47 PM EDT

    Bicara Therapeutics Common Stock Revenue

    Bicara Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Bicara Therapeutics Common Stock generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    55
    Market Cap
    610.56M

    Revenue Chart

    History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist